APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neurocognitive Assessment and Rehabilitation

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neurocognitive Assessment and Rehabilitation Market Analysis and Forecast 2026-2032

2 May 2026220 pages

Choose your research edition.

Industry ResearchNeurocognitive Assessment and Rehabilitation Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurocognitive Assessment and Rehabilitation Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Neurocognitive Assessment and Rehabilitation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurocognitive Assessment and Rehabilitation Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurocognitive Assessment and Rehabilitation Market Analysis and Forecast 2026-2032220 pages · $4,950 USD

Market perspective

The global Neurocognitive Assessment and Rehabilitation market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Neurocognitive Assessment and Rehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neurocognitive Assessment and Rehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neurocognitive Assessment and Rehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neurocognitive Assessment and Rehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Neurocognitive Assessment and Rehabilitation include Cambridge Cognition Holdings plc, Cognifit, Inc., Cogstate Ltd., Lumos Labs, Inc. (Lumosity), CNS Vital Signs, LLC, Posit Science Corporation, BrainCheck, Inc., Constant Therapy Health and NeuronUP SL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Neurocognitive Assessment and Rehabilitation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neurocognitive Assessment and Rehabilitation, also provides the revenue of main regions and countries. Of the upcoming market potential for Neurocognitive Assessment and Rehabilitation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurocognitive Assessment and Rehabilitation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neurocognitive Assessment and Rehabilitation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Neurocognitive Assessment and Rehabilitation revenue, projected growth trends, production technology, application and end-user industry.

Neurocognitive Assessment and Rehabilitation Segment by Company

Cambridge Cognition Holdings plc

Cognifit, Inc.

Cogstate Ltd.

Lumos Labs, Inc. (Lumosity)

CNS Vital Signs, LLC

Posit Science Corporation

BrainCheck, Inc.

Constant Therapy Health

NeuronUP SL

SCHUHFRIED GmbH

Neurocognitive Assessment and Rehabilitation Segment by Type

Neurorehabilitation Therapy

Neurocognitive Assessment Testing

Neurocognitive Assessment and Rehabilitation Segment by Application

Rehab Centers

Hospital & Clinics

Homecare Settings

Physiotherapy Centers

Neurocognitive Assessment and Rehabilitation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurocognitive Assessment and Rehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurocognitive Assessment and Rehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurocognitive Assessment and Rehabilitation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Neurocognitive Assessment and Rehabilitation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Neurocognitive Assessment and Rehabilitation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurocognitive Assessment and Rehabilitation revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neurocognitive Assessment and Rehabilitation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Neurorehabilitation Therapy Major Player Table 3. Neurocognitive Assessment Testing Major Player Table 4. Global Neurocognitive Assessment and Rehabilitation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Rehab Centers Major Player Table 6. Hospital & Clinics Major Player Table 7. Homecare Settings Major Player Table 8. Physiotherapy Centers Major Player Table 9. Neurocognitive Assessment and Rehabilitation Industry Trends Table 10. Neurocognitive Assessment and Rehabilitation Industry Drivers Table 11. Neurocognitive Assessment and Rehabilitation Industry Opportunities and Challenges Table 12. Neurocognitive Assessment and Rehabilitation Industry Restraints Table 13. Global Neurocognitive Assessment and Rehabilitation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Neurocognitive Assessment and Rehabilitation Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Neurocognitive Assessment and Rehabilitation Market Share by Region (2021-2026) Table 16. Global Neurocognitive Assessment and Rehabilitation Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Neurocognitive Assessment and Rehabilitation Market Share by Region (2027-2032) Table 18. Global Neurocognitive Assessment and Rehabilitation Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Players (2021-2026) Table 20. Global Neurocognitive Assessment and Rehabilitation Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Neurocognitive Assessment and Rehabilitation Key Players Headquarters & Area Served Table 22. Global Neurocognitive Assessment and Rehabilitation Players, Product Type & Application Table 23. Global Neurocognitive Assessment and Rehabilitation Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Neurocognitive Assessment and Rehabilitation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Neurocognitive Assessment and Rehabilitation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Type (2021-2026) Table 30. Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Type (2027-2032) Table 31. Global Neurocognitive Assessment and Rehabilitation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Application (2021-2026) Table 35. Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Application (2027-2032) Table 36. Cambridge Cognition Holdings plc Company Information Table 37. Cambridge Cognition Holdings plc Business Overview Table 38. Cambridge Cognition Holdings plc Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Cambridge Cognition Holdings plc Neurocognitive Assessment and Rehabilitation Product Portfolio Table 40. Cambridge Cognition Holdings plc Recent Development Table 41. Cognifit, Inc. Company Information Table 42. Cognifit, Inc. Business Overview Table 43. Cognifit, Inc. Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Cognifit, Inc. Neurocognitive Assessment and Rehabilitation Product Portfolio Table 45. Cognifit, Inc. Recent Development Table 46. Cogstate Ltd. Company Information Table 47. Cogstate Ltd. Business Overview Table 48. Cogstate Ltd. Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Cogstate Ltd. Neurocognitive Assessment and Rehabilitation Product Portfolio Table 50. Cogstate Ltd. Recent Development Table 51. Lumos Labs, Inc. (Lumosity) Company Information Table 52. Lumos Labs, Inc. (Lumosity) Business Overview Table 53. Lumos Labs, Inc. (Lumosity) Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Lumos Labs, Inc. (Lumosity) Neurocognitive Assessment and Rehabilitation Product Portfolio Table 55. Lumos Labs, Inc. (Lumosity) Recent Development Table 56. CNS Vital Signs, LLC Company Information Table 57. CNS Vital Signs, LLC Business Overview Table 58. CNS Vital Signs, LLC Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. CNS Vital Signs, LLC Neurocognitive Assessment and Rehabilitation Product Portfolio Table 60. CNS Vital Signs, LLC Recent Development Table 61. Posit Science Corporation Company Information Table 62. Posit Science Corporation Business Overview Table 63. Posit Science Corporation Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Posit Science Corporation Neurocognitive Assessment and Rehabilitation Product Portfolio Table 65. Posit Science Corporation Recent Development Table 66. BrainCheck, Inc. Company Information Table 67. BrainCheck, Inc. Business Overview Table 68. BrainCheck, Inc. Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. BrainCheck, Inc. Neurocognitive Assessment and Rehabilitation Product Portfolio Table 70. BrainCheck, Inc. Recent Development Table 71. Constant Therapy Health Company Information Table 72. Constant Therapy Health Business Overview Table 73. Constant Therapy Health Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Constant Therapy Health Neurocognitive Assessment and Rehabilitation Product Portfolio Table 75. Constant Therapy Health Recent Development Table 76. NeuronUP SL Company Information Table 77. NeuronUP SL Business Overview Table 78. NeuronUP SL Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. NeuronUP SL Neurocognitive Assessment and Rehabilitation Product Portfolio Table 80. NeuronUP SL Recent Development Table 81. SCHUHFRIED GmbH Company Information Table 82. SCHUHFRIED GmbH Business Overview Table 83. SCHUHFRIED GmbH Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. SCHUHFRIED GmbH Neurocognitive Assessment and Rehabilitation Product Portfolio Table 85. SCHUHFRIED GmbH Recent Development Table 86. North America Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Neurocognitive Assessment and Rehabilitation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Neurocognitive Assessment and Rehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Neurocognitive Assessment and Rehabilitation Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Neurocognitive Assessment and Rehabilitation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Neurocognitive Assessment and Rehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Neurocognitive Assessment and Rehabilitation Revenue by Country (US$ Million) & (2027-2032) Table 100. China Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 101. China Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 102. China Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 103. China Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Neurocognitive Assessment and Rehabilitation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Neurocognitive Assessment and Rehabilitation Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Neurocognitive Assessment and Rehabilitation Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Neurocognitive Assessment and Rehabilitation Image Figure 2. Global Neurocognitive Assessment and Rehabilitation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurocognitive Assessment and Rehabilitation Market Size Share 2021 VS 2025 VS 2032 Figure 4. Neurorehabilitation Therapy Image Figure 5. Neurocognitive Assessment Testing Image Figure 6. Global Neurocognitive Assessment and Rehabilitation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Neurocognitive Assessment and Rehabilitation Market Size Share 2021 VS 2025 VS 2032 Figure 8. Rehab Centers Image Figure 9. Hospital & Clinics Image Figure 10. Homecare Settings Image Figure 11. Physiotherapy Centers Image Figure 12. Global Neurocognitive Assessment and Rehabilitation Market Size (US$ Million) & (2021-2032) Figure 13. Global Neurocognitive Assessment and Rehabilitation Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Neurocognitive Assessment and Rehabilitation Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Neurocognitive Assessment and Rehabilitation Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Neurocognitive Assessment and Rehabilitation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Neurocognitive Assessment and Rehabilitation Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Type (2021-2032) Figure 20. Global Neurocognitive Assessment and Rehabilitation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Application (2021-2032) Figure 23. North America Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Neurocognitive Assessment and Rehabilitation Revenue Share by Type (2021-2032) Figure 25. North America Neurocognitive Assessment and Rehabilitation Revenue Share by Application (2021-2032) Figure 26. North America Neurocognitive Assessment and Rehabilitation Revenue Share by Country (2021-2032) Figure 27. United States Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Neurocognitive Assessment and Rehabilitation Revenue Share by Type (2021-2032) Figure 32. Europe Neurocognitive Assessment and Rehabilitation Revenue Share by Application (2021-2032) Figure 33. Europe Neurocognitive Assessment and Rehabilitation Revenue Share by Country (2021-2032) Figure 34. Germany Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Neurocognitive Assessment and Rehabilitation Revenue Share by Type (2021-2032) Figure 44. China Neurocognitive Assessment and Rehabilitation Revenue Share by Application (2021-2032) Figure 45. Asia Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Neurocognitive Assessment and Rehabilitation Revenue Share by Type (2021-2032) Figure 47. Asia Neurocognitive Assessment and Rehabilitation Revenue Share by Application (2021-2032) Figure 48. Asia Neurocognitive Assessment and Rehabilitation Revenue Share by Region (2021-2032) Figure 49. Japan Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Neurocognitive Assessment and Rehabilitation Revenue Share by Type (2021-2032) Figure 57. SAMEA Neurocognitive Assessment and Rehabilitation Revenue Share by Application (2021-2032) Figure 58. SAMEA Neurocognitive Assessment and Rehabilitation Revenue Share by Country (2021-2032) Figure 59. Brazil Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Neurocognitive Assessment and Rehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Neurorehabilitation Therapy
  • Neurocognitive Assessment Testing
Applications
  • Rehab Centers
  • Hospital & Clinics
  • Homecare Settings
  • Physiotherapy Centers
Companies covered
  • Cambridge Cognition Holdings plc
  • Cognifit, Inc.
  • Cogstate Ltd.
  • Lumos Labs, Inc. (Lumosity)
  • CNS Vital Signs, LLC
  • Posit Science Corporation
  • BrainCheck, Inc.
  • Constant Therapy Health
  • NeuronUP SL
  • SCHUHFRIED GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neurocognitive Assessment and Rehabilitation Market by Type
  3. 1.2.1 Global Neurocognitive Assessment and Rehabilitation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Neurorehabilitation Therapy
  5. 1.2.3 Neurocognitive Assessment Testing
  6. 1.3 Neurocognitive Assessment and Rehabilitation Market by Application
  7. 1.3.1 Global Neurocognitive Assessment and Rehabilitation Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Rehab Centers
  9. 1.3.3 Hospital & Clinics
  10. 1.3.4 Homecare Settings
  11. 1.3.5 Physiotherapy Centers
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Neurocognitive Assessment and Rehabilitation Market Dynamics
  1. 2.1 Neurocognitive Assessment and Rehabilitation Industry Trends
  2. 2.2 Neurocognitive Assessment and Rehabilitation Industry Drivers
  3. 2.3 Neurocognitive Assessment and Rehabilitation Industry Opportunities and Challenges
  4. 2.4 Neurocognitive Assessment and Rehabilitation Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Neurocognitive Assessment and Rehabilitation Market Perspective (2021-2032)
  2. 3.2 Global Neurocognitive Assessment and Rehabilitation Growth Trends by Region
  3. 3.2.1 Global Neurocognitive Assessment and Rehabilitation Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neurocognitive Assessment and Rehabilitation Market Size by Region (2021-2026)
  5. 3.2.3 Global Neurocognitive Assessment and Rehabilitation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Neurocognitive Assessment and Rehabilitation Revenue by Players
  2. 4.1.1 Global Neurocognitive Assessment and Rehabilitation Revenue by Players (2021-2026)
  3. 4.1.2 Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Neurocognitive Assessment and Rehabilitation Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neurocognitive Assessment and Rehabilitation Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Neurocognitive Assessment and Rehabilitation Key Players Headquarters & Area Served
  7. 4.4 Global Neurocognitive Assessment and Rehabilitation Players, Product Type & Application
  8. 4.5 Global Neurocognitive Assessment and Rehabilitation Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Neurocognitive Assessment and Rehabilitation Market CR5 and HHI
  11. 4.6.3 2025 Neurocognitive Assessment and Rehabilitation Tier 1, Tier 2, and Tier 3
5 Neurocognitive Assessment and Rehabilitation Market Size by Type
  1. 5.1 Global Neurocognitive Assessment and Rehabilitation Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2032)
  3. 5.3 Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Type (2021-2032)
6 Neurocognitive Assessment and Rehabilitation Market Size by Application
  1. 6.1 Global Neurocognitive Assessment and Rehabilitation Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2032)
  3. 6.3 Global Neurocognitive Assessment and Rehabilitation Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Cambridge Cognition Holdings plc
  2. 7.1.1 Cambridge Cognition Holdings plc Company Information
  3. 7.1.2 Cambridge Cognition Holdings plc Business Overview
  4. 7.1.3 Cambridge Cognition Holdings plc Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Cambridge Cognition Holdings plc Neurocognitive Assessment and Rehabilitation Product Portfolio
  6. 7.1.5 Cambridge Cognition Holdings plc Recent Developments
  7. 7.2 Cognifit, Inc.
  8. 7.2.1 Cognifit, Inc. Company Information
  9. 7.2.2 Cognifit, Inc. Business Overview
  10. 7.2.3 Cognifit, Inc. Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cognifit, Inc. Neurocognitive Assessment and Rehabilitation Product Portfolio
  12. 7.2.5 Cognifit, Inc. Recent Developments
  13. 7.3 Cogstate Ltd.
  14. 7.3.1 Cogstate Ltd. Company Information
  15. 7.3.2 Cogstate Ltd. Business Overview
  16. 7.3.3 Cogstate Ltd. Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cogstate Ltd. Neurocognitive Assessment and Rehabilitation Product Portfolio
  18. 7.3.5 Cogstate Ltd. Recent Developments
  19. 7.4 Lumos Labs, Inc. (Lumosity)
  20. 7.4.1 Lumos Labs, Inc. (Lumosity) Company Information
  21. 7.4.2 Lumos Labs, Inc. (Lumosity) Business Overview
  22. 7.4.3 Lumos Labs, Inc. (Lumosity) Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Lumos Labs, Inc. (Lumosity) Neurocognitive Assessment and Rehabilitation Product Portfolio
  24. 7.4.5 Lumos Labs, Inc. (Lumosity) Recent Developments
  25. 7.5 CNS Vital Signs, LLC
  26. 7.5.1 CNS Vital Signs, LLC Company Information
  27. 7.5.2 CNS Vital Signs, LLC Business Overview
  28. 7.5.3 CNS Vital Signs, LLC Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CNS Vital Signs, LLC Neurocognitive Assessment and Rehabilitation Product Portfolio
  30. 7.5.5 CNS Vital Signs, LLC Recent Developments
  31. 7.6 Posit Science Corporation
  32. 7.6.1 Posit Science Corporation Company Information
  33. 7.6.2 Posit Science Corporation Business Overview
  34. 7.6.3 Posit Science Corporation Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Posit Science Corporation Neurocognitive Assessment and Rehabilitation Product Portfolio
  36. 7.6.5 Posit Science Corporation Recent Developments
  37. 7.7 BrainCheck, Inc.
  38. 7.7.1 BrainCheck, Inc. Company Information
  39. 7.7.2 BrainCheck, Inc. Business Overview
  40. 7.7.3 BrainCheck, Inc. Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (2021-2026)
  41. 7.7.4 BrainCheck, Inc. Neurocognitive Assessment and Rehabilitation Product Portfolio
  42. 7.7.5 BrainCheck, Inc. Recent Developments
  43. 7.8 Constant Therapy Health
  44. 7.8.1 Constant Therapy Health Company Information
  45. 7.8.2 Constant Therapy Health Business Overview
  46. 7.8.3 Constant Therapy Health Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Constant Therapy Health Neurocognitive Assessment and Rehabilitation Product Portfolio
  48. 7.8.5 Constant Therapy Health Recent Developments
  49. 7.9 NeuronUP SL
  50. 7.9.1 NeuronUP SL Company Information
  51. 7.9.2 NeuronUP SL Business Overview
  52. 7.9.3 NeuronUP SL Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (2021-2026)
  53. 7.9.4 NeuronUP SL Neurocognitive Assessment and Rehabilitation Product Portfolio
  54. 7.9.5 NeuronUP SL Recent Developments
  55. 7.10 SCHUHFRIED GmbH
  56. 7.10.1 SCHUHFRIED GmbH Company Information
  57. 7.10.2 SCHUHFRIED GmbH Business Overview
  58. 7.10.3 SCHUHFRIED GmbH Neurocognitive Assessment and Rehabilitation Revenue and Gross Margin (2021-2026)
  59. 7.10.4 SCHUHFRIED GmbH Neurocognitive Assessment and Rehabilitation Product Portfolio
  60. 7.10.5 SCHUHFRIED GmbH Recent Developments
8 North America
  1. 8.1 North America Neurocognitive Assessment and Rehabilitation Revenue (2021-2032)
  2. 8.2 North America Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2032)
  3. 8.2.1 North America Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026)
  4. 8.2.2 North America Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032)
  5. 8.3 North America Neurocognitive Assessment and Rehabilitation Revenue Share by Type (2021-2032)
  6. 8.4 North America Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2032)
  7. 8.4.1 North America Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026)
  8. 8.4.2 North America Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032)
  9. 8.5 North America Neurocognitive Assessment and Rehabilitation Revenue Share by Application (2021-2032)
  10. 8.6 North America Neurocognitive Assessment and Rehabilitation Revenue by Country
  11. 8.6.1 North America Neurocognitive Assessment and Rehabilitation Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Neurocognitive Assessment and Rehabilitation Revenue by Country (2021-2026)
  13. 8.6.3 North America Neurocognitive Assessment and Rehabilitation Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Neurocognitive Assessment and Rehabilitation Revenue (2021-2032)
  2. 9.2 Europe Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2032)
  3. 9.2.1 Europe Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026)
  4. 9.2.2 Europe Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032)
  5. 9.3 Europe Neurocognitive Assessment and Rehabilitation Revenue Share by Type (2021-2032)
  6. 9.4 Europe Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2032)
  7. 9.4.1 Europe Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026)
  8. 9.4.2 Europe Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032)
  9. 9.5 Europe Neurocognitive Assessment and Rehabilitation Revenue Share by Application (2021-2032)
  10. 9.6 Europe Neurocognitive Assessment and Rehabilitation Revenue by Country
  11. 9.6.1 Europe Neurocognitive Assessment and Rehabilitation Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Neurocognitive Assessment and Rehabilitation Revenue by Country (2021-2026)
  13. 9.6.3 Europe Neurocognitive Assessment and Rehabilitation Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Neurocognitive Assessment and Rehabilitation Revenue (2021-2032)
  2. 10.2 China Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2032)
  3. 10.2.1 China Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026)
  4. 10.2.2 China Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032)
  5. 10.3 China Neurocognitive Assessment and Rehabilitation Revenue Share by Type (2021-2032)
  6. 10.4 China Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2032)
  7. 10.4.1 China Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026)
  8. 10.4.2 China Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032)
  9. 10.5 China Neurocognitive Assessment and Rehabilitation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neurocognitive Assessment and Rehabilitation Revenue (2021-2032)
  2. 11.2 Asia Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2032)
  3. 11.2.1 Asia Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026)
  4. 11.2.2 Asia Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032)
  5. 11.3 Asia Neurocognitive Assessment and Rehabilitation Revenue Share by Type (2021-2032)
  6. 11.4 Asia Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2032)
  7. 11.4.1 Asia Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026)
  8. 11.4.2 Asia Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032)
  9. 11.5 Asia Neurocognitive Assessment and Rehabilitation Revenue Share by Application (2021-2032)
  10. 11.6 Asia Neurocognitive Assessment and Rehabilitation Revenue by Country
  11. 11.6.1 Asia Neurocognitive Assessment and Rehabilitation Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Neurocognitive Assessment and Rehabilitation Revenue by Country (2021-2026)
  13. 11.6.3 Asia Neurocognitive Assessment and Rehabilitation Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neurocognitive Assessment and Rehabilitation Revenue (2021-2032)
  2. 12.2 SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Type (2027-2032)
  5. 12.3 SAMEA Neurocognitive Assessment and Rehabilitation Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Application (2027-2032)
  9. 12.5 SAMEA Neurocognitive Assessment and Rehabilitation Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Country
  11. 12.6.1 SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Neurocognitive Assessment and Rehabilitation Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst